Synergy of Irofulven in combination with various anti-metabolites, enzyme inhibitors, and miscellaneous agents in MV522 lung carcinoma cells: marked interaction with gemcitabine and 5-fluorouracil
Michael J. Kelner, Trevor C. McMorris, Rafael J. Rojas, Leita A. Estes, Pharnuk SuthipinijthamVolume:
26
Language:
english
Pages:
9
DOI:
10.1007/s10637-008-9113-8
Date:
October, 2008
File:
PDF, 213 KB
english, 2008